Literature DB >> 8853725

Risk factors associated with Epstein-Barr virus replication in oral epithelial cells of HIV-infected individuals.

A W Boulter1, N Soltanpoor, A V Swan, W Birnbaum, N W Johnson, C G Teo.   

Abstract

OBJECTIVE: To examine risk factors associated with Epstein-Barr virus (EBV) replication in the oral epithelium of an HIV-infected cohort.
DESIGN: Longitudinal study of behavioural, medication and immunological parameters of HIV-1-seropositive outpatients attending a genitourinary clinic. Outcome measure was EBV DNA positivity in curetted oral squames, as detected by in situ hybridization. Logistic regression for repeated observations of the same individuals was used to analyse how risk changed over time.
RESULTS: Fifty six individuals were studied; 158 patient-visits were made in total (mean, 2.8). Of 137 samples curetted from the tongue, 36 were positive for EBV DNA. Recreational drug use, oral sexual practices, therapy with zidovudine and aciclovir, and changes in CD4 and total lymphocyte counts were not associated with changes in risk. Alcohol drinking, elevated CD8 lymphocyte counts and fluconazole therapy were associated with a decreased risk, and cigarette smoking with increased risk.
CONCLUSION: Behavioural and HIV-specific immunological changes may play important roles in promoting and affecting the course of oral EBV replication. Rigorous anticandidal therapy and avoidance of cigarette smoking may retard the development of oral hairy leukoplakia.

Entities:  

Mesh:

Year:  1996        PMID: 8853725     DOI: 10.1097/00002030-199610090-00002

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  5 in total

1.  A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings.

Authors:  Gary L Humfleet; Sharon M Hall; Kevin L Delucchi; James W Dilley
Journal:  Nicotine Tob Res       Date:  2013-02-19       Impact factor: 4.244

2.  Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium.

Authors:  Sharof Tugizov; Rossana Herrera; Piri Veluppillai; John Greenspan; Deborah Greenspan; Joel M Palefsky
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

3.  Comparison of commercial real-time PCR assays for quantification of Epstein-Barr virus DNA.

Authors:  Guillermo Ruiz; Pilar Peña; Fernando de Ory; Juan Emilio Echevarría
Journal:  J Clin Microbiol       Date:  2005-05       Impact factor: 5.948

4.  Oral manifestations as predictors of immune suppression in a HIV-/AIDS-infected population in south India.

Authors:  Gaurav Sharma; Keerthilatha M Pai; Suhas Setty; John T Ramapuram; Archna Nagpal
Journal:  Clin Oral Investig       Date:  2008-07-31       Impact factor: 3.573

5.  Characteristics of HIV-positive cigarette smokers: a sample of smokers facing multiple challenges.

Authors:  Gary L Humfleet; Kevin Delucchi; Kevin Kelley; Sharon M Hall; James Dilley; George Harrison
Journal:  AIDS Educ Prev       Date:  2009-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.